9.69
-0.36
(-3.58%)
At close: 12:46:21 PM GMT+8
Key Executives
Amounts are as of -- and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in TWD.
| Name | Title | Pay | Exercised | Year Born |
|---|---|---|---|---|
| Dr. Jassy Wang | Chief Exec. Officer | -- | -- | -- |
MegaPro Biomedical Co., Ltd
- Sector:
- Healthcare
- Industry: Biotechnology
Description
MegaPro Biomedical Co., Ltd, a biotech company, focuses on the development of nano drugs. It also develops MPB-1523, an IOP injection that is in Phase II clinical trial for use in the treatment of hepatocellular carcinoma; and MPB-1514, an iron injection that is in Phase II clinical trial for use in the treatment of iron deficiency anemia, as well as MPB-1734, an anti-cancer drug that is in preclinical trial for the treatment of malignant tumor. The company was founded in 2014 and is based in Zhubei, Taiwan.
Corporate Governance
MegaPro Biomedical Co., Ltd’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.
Upcoming Events
Upcoming Events Information Not Available
Recent Events
Recent Events Information Not Available
Related Tickers
6744.TWO Feng Chi Biotech Corp.
18.30
0.00%
6848.TWO RBC Bioscience Corporation
18.00
0.00%
7607.TWO DuoGenic StemCells corporation
15.00
+0.33%
4197.TWO Visgeneer Inc.
10.05
0.00%
7754.TWO AnnJi
19.70
-13.22%
6917.TWO Andros Pharmaceuticals Co.,Ltd
16.70
+1.83%
4194.TWO Holy Stone Healthcare Co., Ltd.
7.17
-5.03%
6652.TWO Eusol Biotech Co.,Ltd.
6.19
+2.15%
6999.TWO Han Biomedical
42.15
0.00%
7729.TWO SBI
22.30
-7.66%